Maternal pertussis immunization in Finland, 4 years (MIFI-4Y)

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-510787-23-00

Acronym

MIFI-4Y

Enrollment

138

Registered

2024-04-30

Start date

2024-05-07

Completion date

2025-07-07

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pertussis

Brief summary

PT-specific IgG antibody geometric mean concentration (GMC) at 4 years+28 days in children from Arm 1 versus Arm 2.

Interventions

DRUGTetravac

DRUGinjektioneste

DRUGsuspensio Adsorboitu kurkkumätä-

DRUGjäykkäkouristus-

DRUGhinkuyskä- (soluton

DRUGkomponentti) ja polio (inaktivoitu) - rokote

Eligibility

Sex/Gender

All

Age

0 Years to 64 Years

Design outcomes

Primary

Measure	Time frame
PT-specific IgG antibody geometric mean concentration (GMC) at 4 years+28 days in children from Arm 1 versus Arm 2.	—

Countries

Finland

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026